Management Team

Elliott Gruskin is a respected R&D leader and global pharmaceutical operating executive with expertise in transforming innovative research concepts into commercial opportunities. As Executive Director, Research, Strategy & Innovation at Mallinckrodt Pharmaceuticals, he has led cross-functional collaboration in a complex matrixed environment to achieve high impact business results.

Steven Romano is a seasoned pharmaceutical executive with over 25 years of research, development and medical affairs experience across a wide range of therapeutic areas and drug development. Dr. Romano serves as Chief Medical Officer and Head, Research and Development, at Silence Therapeutics, a development stage biopharmaceutical company.

Rashmin Savani is Professor, Nemours Eminent Scholar, and Chair of Pediatrics at the University of Florida College of Medicine in Gainesville. An internationally recognized expert in cell biology, his research primarily focuses on lung development, injury and repair, including mechanisms of extracellular matrix regulation of inflammation and angiogenesis.